About
Sanguina, Inc. is a biotechnology company based in Georgia that focuses on accessible digital and at-home health platforms, particularly for blood health and anemia management. Founded in 2019 as a spin-off from several prestigious institutions, Sanguina empowers individuals to diagnose, monitor, and manage their health from home. The company offers innovative products, including the AnemoCheck Home, an FDA-cleared anemia screening test kit that allows users to conveniently monitor their blood hemoglobin levels at home. Complementing this is the Ruby App, which provides personalized blood health insights and wellness management tools. The app features a Premium Subscription that enhances result accuracy through advanced algorithms. Sanguina's technology utilizes smartphone-based tools, such as a "fingernail selfie" method, to estimate blood hemoglobin levels non-invasively. The company targets individuals affected by anemia, healthcare providers, and wellness-focused consumers seeking convenient diagnostic solutions. With over $4 million in funding, Sanguina is dedicated to expanding its digital and home-based health platforms.
Technologies
Keywords
Company Information
-
Employees 19
-
Founded 2014
-
Annual Revenue $3111000
-
Total Funding $5100000
Location
147 Technology Parkway Northwest, Norcross, Georgia, United States, 30092
